Álvarez-Mon Melchor, Ortega Miguel A, Gasulla Óscar, Fortuny-Profitós Jordi, Mazaira-Font Ferran A, Saurina Pablo, Monserrat Jorge, Plana María N, Troncoso Daniel, Moreno José Sanz, Muñoz Benjamin, Arranz Alberto, Varona Jose F, Lopez-Escobar Alejandro, Barco Angel Asúnsolo-Del
Service of Internal Medicine and Immune System Diseases-Rheumatology, University Hospital Príncipe de Asturias, (CIBEREHD), 28806 Alcalá de Henares, Spain.
Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain.
J Pers Med. 2021 Jan 8;11(1):36. doi: 10.3390/jpm11010036.
This study aimed to create an individualized analysis model of the risk of intensive care unit (ICU) admission or death for coronavirus disease 2019 (COVID-19) patients as a tool for the rapid clinical management of hospitalized patients in order to achieve a resilience of medical resources. This is an observational, analytical, retrospective cohort study with longitudinal follow-up. Data were collected from the medical records of 3489 patients diagnosed with COVID-19 using RT-qPCR in the period of highest community transmission recorded in Europe to date: February-June 2020. The study was carried out in in two health areas of hospital care in the Madrid region: the central area of the Madrid capital (Hospitales de Madrid del Grupo HM Hospitales (CH-HM), = 1931) and the metropolitan area of Madrid (Hospital Universitario Príncipe de Asturias (MH-HUPA) = 1558). By using a regression model, we observed how the different patient variables had unequal importance. Among all the analyzed variables, basal oxygen saturation was found to have the highest relative importance with a value of 20.3%, followed by age (17.7%), lymphocyte/leukocyte ratio (14.4%), CRP value (12.5%), comorbidities (12.5%), and leukocyte count (8.9%). Three levels of risk of ICU/death were established: low-risk level (<5%), medium-risk level (5-20%), and high-risk level (>20%). At the high-risk level, 13% needed ICU admission, 29% died, and 37% had an ICU-death outcome. This predictive model allowed us to individualize the risk for worse outcome for hospitalized patients affected by COVID-19.
本研究旨在创建一个针对2019冠状病毒病(COVID-19)患者入住重症监护病房(ICU)或死亡风险的个体化分析模型,作为住院患者快速临床管理的工具,以实现医疗资源的弹性调配。这是一项具有纵向随访的观察性、分析性、回顾性队列研究。数据收集自2020年2月至6月欧洲迄今记录的社区传播高峰期,3489例经逆转录定量聚合酶链反应(RT-qPCR)确诊为COVID-19患者的病历。该研究在马德里地区的两个医院护理健康区域进行:马德里市中心区域(马德里集团HM医院(CH-HM),n = 1931)和马德里大都市区(阿斯图里亚斯王子大学医院(MH-HUPA),n = 1558)。通过使用回归模型,我们观察到不同的患者变量重要性不等。在所有分析变量中,基础血氧饱和度的相对重要性最高,为20.3%,其次是年龄(17.7%)、淋巴细胞/白细胞比值(14.4%)、C反应蛋白值(12.5%)、合并症(12.5%)和白细胞计数(8.9%)。确定了三个ICU/死亡风险级别:低风险级别(<5%)、中等风险级别(5-20%)和高风险级别(>20%)。在高风险级别中,13%的患者需要入住ICU,29%的患者死亡,37%的患者出现ICU死亡结局。这个预测模型使我们能够针对受COVID-19影响的住院患者个体化评估其预后不良的风险。